Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Acute kidney injury after TAVR: Key risk factors every cardiologist should know
Multiple studies have linked acute kidney injury after TAVR to a heightened risk of short- and long-term mortality.
FDA approves JenaValve TAVR system for aortic regurgitation
The Trilogy Transcatheter Heart Valve System is the first TAVR device approved by the FDA to treat severe aortic regurgitation. Until now, interventional cardiologists have had to settle for the off-label use of TAVR valves built for treating aortic stenosis.
Pioneer cardiologist Amir Lerman remembered as a ‘true giant’ of the specialty
Lerman, who spent nearly 40 years with Mayo Clinic, was especially influential in the treatment of nonobstructive CAD.
Trump’s EPA wants to roll back Biden-era pollution limits for medical device sterilization
Ethylene oxide is an odorless gas used to sterilize pacemakers, leads, stents and many other medical devices. Long-term exposure, however, can cause cancer. The Biden administration made it a priority to reduce ethylene oxide emissions, but many critics thought those cuts were too extreme.
Imaging evaluations and PCI planning: Heartflow announces ‘tremendous progress’ for AI portfolio
Heartflow's AI technologies are at the center of multiple ACC.26 presentations. In addition, the company announced, the first patient was enrolled into the NAVIGATE-PCI registry.

Acute kidney injury after TAVR: Key risk factors every cardiologist should know

Multiple studies have linked acute kidney injury after TAVR to a heightened risk of short- and long-term mortality.

FDA approves JenaValve TAVR system for aortic regurgitation

The Trilogy Transcatheter Heart Valve System is the first TAVR device approved by the FDA to treat severe aortic regurgitation. Until now, interventional cardiologists have had to settle for the off-label use of TAVR valves built for treating aortic stenosis.

Amir Lerman, MD, a veteran cardiologist with Mayo Clinic, died unexpectedly on Feb. 23. He was 69 years old.

Pioneer cardiologist Amir Lerman remembered as a ‘true giant’ of the specialty

Lerman, who spent nearly 40 years with Mayo Clinic, was especially influential in the treatment of nonobstructive CAD.

Trump’s EPA wants to roll back Biden-era pollution limits for medical device sterilization

Ethylene oxide is an odorless gas used to sterilize pacemakers, leads, stents and many other medical devices. Long-term exposure, however, can cause cancer. The Biden administration made it a priority to reduce ethylene oxide emissions, but many critics thought those cuts were too extreme.

Imaging evaluations and PCI planning: Heartflow announces ‘tremendous progress’ for AI portfolio

Heartflow's AI technologies are at the center of multiple ACC.26 presentations. In addition, the company announced, the first patient was enrolled into the NAVIGATE-PCI registry.

Heart failure hospitalizations after PCI: a warning sign of ‘exceptionally high risk’

Nonfatal adverse events after PCI are associated with an increased risk of two-year mortality. That risk is especially high, it seems, when patients are hospitalized for heart failure symptoms such as shortness of breath and edema.

Several interventional cardiology late-breaking studies were presented at the Cardiovascular Research Technologies (CRT) 2026 meeting March 7-10, and experts from the Society of Society highlighted what they felt was most impactful to clinical practice. Photo by Dave Fornell.

CRT 2026: Key takeaways for interventional cardiologists

CRT studies shed new light on many topics, including long-term TAVR outcomes, radiation protection and advanced interventional techniques.

Cardiology practice, cardiologists pay $4.75M to resolve DOJ fraud allegations

The physicians allegedly performed medically unnecessary ablation procedures as part of a years-long fraud scheme.